technetium tc 99m hydroxymethylene diphosphonate has been researched along with Camurati-Engelmann Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kadoya, M; Momose, M; Yanagisawa, S; Yoshida, K | 1 |
Arai, Y; Hasegawa, T; Maeda, T; Miyake, M; Sugimura, K; Tateishi, U | 1 |
Aburano, T; Okuno, A; Sakuraba, N; Shuke, N; Takashio, T; Usui, K; Yamamoto, W | 1 |
3 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Camurati-Engelmann Disease
Article | Year |
---|---|
Camurati-Engelmann disease on a 99mTc-HMDP bone scan.
Topics: Bone and Bones; Camurati-Engelmann Syndrome; Female; Humans; Middle Aged; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2008 |
Diaphyseal medullary stenosis with pleomorphic malignant fibrous histiocytoma of the bone: 99mTc hydroxymethylenediphosphonate and 201Tl chloride scintigraphy findings.
Topics: Adult; Bone Neoplasms; Camurati-Engelmann Syndrome; Histiocytoma, Malignant Fibrous; Humans; Male; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Thallium | 2006 |
Bone scintigraphy in a patient with progressive diaphyseal dysplasia.
Topics: Adult; Bone and Bones; Camurati-Engelmann Syndrome; Female; Humans; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate | 1997 |